These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 35628192)

  • 1. Quest for Quality in Translational Stroke Research-A New Dawn for Neuroprotection?
    Haupt M; Gerner ST; Bähr M; Doeppner TR
    Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Free radical trapping as a therapeutic approach to neuroprotection in stroke: experimental and clinical studies with NXY-059 and free radical scavengers.
    Green AR; Ashwood T
    Curr Drug Targets CNS Neurol Disord; 2005 Apr; 4(2):109-18. PubMed ID: 15857295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A critical appraisal of the NXY-059 neuroprotection studies for acute stroke: a need for more rigorous testing of neuroprotective agents in animal models of stroke.
    Savitz SI
    Exp Neurol; 2007 May; 205(1):20-5. PubMed ID: 17408618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroprotection in cerebral ischaemia: facts and fancies--the need for new approaches.
    Wahlgren NG; Ahmed N
    Cerebrovasc Dis; 2004; 17 Suppl 1():153-66. PubMed ID: 14694293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroprotection for stroke: current status and future perspectives.
    Minnerup J; Sutherland BA; Buchan AM; Kleinschnitz C
    Int J Mol Sci; 2012; 13(9):11753-11772. PubMed ID: 23109881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroprotective Strategies for Ischemic Stroke-Future Perspectives.
    Haupt M; Gerner ST; Bähr M; Doeppner TR
    Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36901765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nitrone-related therapeutics: potential of NXY-059 for the treatment of acute ischaemic stroke.
    Maples KR; Green AR; Floyd RA
    CNS Drugs; 2004; 18(15):1071-84. PubMed ID: 15581379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
    Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
    Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methodological quality of animal studies of neuroprotective agents currently in phase II/III acute ischemic stroke trials.
    Philip M; Benatar M; Fisher M; Savitz SI
    Stroke; 2009 Feb; 40(2):577-81. PubMed ID: 19074479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroprotection in stroke: the importance of collaboration and reproducibility.
    Neuhaus AA; Couch Y; Hadley G; Buchan AM
    Brain; 2017 Aug; 140(8):2079-2092. PubMed ID: 28641383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anesthetic neuroprotection: antecedents and an appraisal of preclinical and clinical data quality.
    Ishida K; Berger M; Nadler J; Warner DS
    Curr Pharm Des; 2014; 20(36):5751-65. PubMed ID: 24502575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Future of neuroprotection for acute stroke: in the aftermath of the SAINT trials.
    Savitz SI; Fisher M
    Ann Neurol; 2007 May; 61(5):396-402. PubMed ID: 17420989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroprotection for ischemic stroke: past, present and future.
    Ginsberg MD
    Neuropharmacology; 2008 Sep; 55(3):363-89. PubMed ID: 18308347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PRIMED
    Bahr-Hosseini M; Bikson M; Iacoboni M; Liebeskind DS; Hinman JD; Carmichael ST; Saver JL
    Transl Stroke Res; 2022 Apr; 13(2):222-227. PubMed ID: 34196953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Life after cerovive: a personal perspective on ischemic neuroprotection in the post-NXY-059 era.
    Ginsberg MD
    Stroke; 2007 Jun; 38(6):1967-72. PubMed ID: 17478741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of the nitrone-based spin trap agent NXY-059 to treat acute ischemic stroke.
    Lapchak PA; Araujo DM
    CNS Drug Rev; 2003; 9(3):253-62. PubMed ID: 14530797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroprotection for ischaemic stroke: translation from the bench to the bedside.
    Sutherland BA; Minnerup J; Balami JS; Arba F; Buchan AM; Kleinschnitz C
    Int J Stroke; 2012 Jul; 7(5):407-18. PubMed ID: 22394615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Past, present and future of neuroprotection].
    Mracek J
    Cas Lek Cesk; 2010; 149(12):586-90. PubMed ID: 21387585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroprotection in acute ischemic stroke.
    Reza Noorian A; Nogueira R; Gupta R
    J Neurosurg Sci; 2011 Jun; 55(2):127-38. PubMed ID: 21623325
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.